PMID- 29797252 OWN - NLM STAT- MEDLINE DCOM- 20190221 LR - 20190221 IS - 1940-6029 (Electronic) IS - 1064-3745 (Linking) VI - 1792 DP - 2018 TI - Fluorescence In Situ Hybridization (FISH) in Multiple Myeloma. PG - 55-69 LID - 10.1007/978-1-4939-7865-6_5 [doi] AB - The application of fluorescence in situ hybridization (FISH) technology in diagnosis and molecular classification of cancer-risk has become an essential tool in the proceeding of personalized therapy. In multiple myeloma, the precise FISH detection of numerical and structural genetic aberrations can be carried out on metaphase chromosome spreads, interphase nuclei, and formalin fixed paraffin-embedded (FFPE) tissues. To dissect highly complex cancer genomes, a broad variety of novel DNA probes, which outpace supplies from commercial resources on the market, are also crucial to the advanced translational researches. Here, we provide the protocols for the creation of custom-made DNA probes and for conducting hybridizations on various targeting cells and tissues. FAU - Tian, Erming AU - Tian E AD - Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. tianerming@uams.edu. LA - eng PT - Journal Article PL - United States TA - Methods Mol Biol JT - Methods in molecular biology (Clifton, N.J.) JID - 9214969 RN - 0 (Biomarkers, Tumor) RN - 0 (DNA Probes) SB - IM MH - Biomarkers, Tumor MH - Bone Marrow/metabolism/pathology MH - DNA Probes MH - Humans MH - Immunohistochemistry MH - *In Situ Hybridization, Fluorescence/methods MH - Interphase/genetics MH - Metaphase/genetics MH - Multiple Myeloma/diagnosis/*genetics OTO - NOTNLM OT - Cancer cytogenetics OT - DNA probes OT - FISH EDAT- 2018/05/26 06:00 MHDA- 2019/02/23 06:00 CRDT- 2018/05/26 06:00 PHST- 2018/05/26 06:00 [entrez] PHST- 2018/05/26 06:00 [pubmed] PHST- 2019/02/23 06:00 [medline] AID - 10.1007/978-1-4939-7865-6_5 [doi] PST - ppublish SO - Methods Mol Biol. 2018;1792:55-69. doi: 10.1007/978-1-4939-7865-6_5.